Status:
UNKNOWN
Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty
Lead Sponsor:
Colorado Joint Replacement
Conditions:
Degenerative Osteoarthritis
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
This study is being done to investigate the colonization rate(growth rate) of a particular type of low-virulence (does not typically cause infection) bacterium called Propionibacterium, more specifica...
Detailed Description
This study is being done to investigate the colonization rate(growth rate) of a particular type of low-virulence (does not typically cause infection) bacterium called Propionibacterium. The most commo...
Eligibility Criteria
Inclusion
- Patients who are 18 to 79 85 years of age
- CJR primary joint arthroplasty patients who are receiving care at Porter Adventist Hospital
- CJR established primary knee or hip arthroplasty patients with a native hip joint (no replacement on the biopsy side) who volunteers as a research participant.
- CJR patients without a previous arthroplasty procedure who have established care with our practice.
Exclusion
- Previous history of hip infection
- Current antibiotic use or antibiotic use within the past week
- Previous history of Cutibacterium joint infection
- Current immunodeficiency disease or disorder
- Patients with active psoriatic disease or other focal inflammation over the hip
- Previous total hip arthroplasty (bilateral for the case of TKA patients and healthy volunteers, contralateral for THA patients)
Key Trial Info
Start Date :
February 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
496 Patients enrolled
Trial Details
Trial ID
NCT03849885
Start Date
February 2 2019
End Date
December 31 2024
Last Update
January 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Colorado Joint Replacement
Denver, Colorado, United States, 80210